Total Revenue: $205.8 million, up 74% from the first quarter of 2023. NUPLAZID Sales: $129.9 million, a 10% increase from the previous year. DAYBUE Sales: $75.9 million, marking its first full ...

Acadia Pharmaceuticals Inc. ACAD reported first-quarter 2024 earnings of 10 cents per share, beating the Zacks Consensus Estimate of 4 cents. In the year-ago quarter, the company had incurred a ...

MANILA, Philippines — Extreme heat driven by climate change has forced the government to speed up its return to the old school calendar, with President Ferdinand Marcos Jr. himself asking Vice ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

After hours: May 31 at 4:57 PM EDT Loading Chart for ACAD ...

I am only making incremental moves -- including this options play for Acadia Pharmaceuticals -- during what I think is an inflection point for the markets right now.

These special topic courses focus on the development of academic skills, attitudes, and habits necessary for college success. Selected topics may include the transition to university life for specific ...

Open data in science education research: editorial in the journal Ensaio Pesquisa em Educação em Ciências highlights perspectives and challenges Editorial discusses the challenges and benefits of ...

Top management team (TMT) play key roles in many industries and firms. Human resources is continuously developed and considered to be a competitive advantage. Traditional research on TMT has, however, ...